October 2024 Price Concessions Final Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/10/2024) announced the following final list of price concessions for October 2024:
| Drug | Pack size | Price concession |
| Amantadine 100mg capsules | 56 | £17.66 |
| Apixaban 2.5mg tablets | 60 | £7.21 |
| Apixaban 5mg tablets | 56 | £5.63 |
| Aqueous cream | 500 | £6.59 |
| Ascorbic acid 500mg tablets | 28 | £36.86 |
| Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel | 60 | £23.46 |
| Carbimazole 5mg tablets | 100 | £10.65 (previously £1.98) |
| Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops | 5 | £5.18 |
| Erythromycin 250mg gastro-resistant tablets | 28 | £10.41 |
| Erythromycin ethyl succinate 250mg/5ml oral suspension sugar free | 100 | £14.06 |
| Escitalopram 5mg tablets | 28 | £2.39 |
| Gabapentin 800mg tablets | 100 | £47.20 |
| Haloperidol 1.5mg tablets | 28 | £8.20 |
| Haloperidol 5mg tablets | 28 | £7.64 |
| Hydrocortisone 10mg tablets | 30 | £1.88 |
| Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules | 10 | £40.00 |
| Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops | 2.5 | £3.80 |
| Levetiracetam 250mg tablets | 60 | £1.83 |
| Lofepramine 70mg tablets | 56 | £24.50 |
| Lorazepam 1mg tablets | 28 | £6.82 |
| Metformin 1g modified-release tablets | 56 | £4.11 |
| Midazolam 10mg/2ml solution for injection ampoules | 10 | £5.58 |
| Morphine sulfate 10mg/1ml solution for injection ampoules | 10 | £5.40 |
| Naftidrofuryl 100mg capsules | 84 | £10.05 |
| Nicorandil 10mg tablets | 60 | £7.58 |
| Nicorandil 20mg tablets | 60 | £14.56 |
| Olanzapine 20mg tablets | 28 | £4.06 |
| Oxcarbazepine 600mg tablets | 50 | £29.90 |
| Oxycodone 5mg/5ml oral solution sugar free | 250 | £8.48 |
| Oxytetracycline 250mg tablets | 28 | £15.23 |
| Pregabalin 300mg capsules | 56 | £2.76 |
| Telmisartan 80mg tablets | 28 | £14.47 |
| Terbinafine 250mg tablets | 14 | £3.50 |
For the full list of price concessions granted for October 2024 please visit our price concession hub page here.
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
In May 2023, DHSC implemented a process to roll over to the following month any agreed prices for concessions requested on or after the 23rd of the month.
Furthermore, from April 2024, a retrospective top-up payment system applies to products granted very low concessionary prices by DHSC when compared to the average purchase prices identified via the Margins survey. Further information on the top-up mechanism can be found here.
Please see our latest funding and reimbursement short video for further information on the recent changes to the price concession process.
